Our analysis reveals that Aβ4–x is restricted mainly to amyloid plaque cores and CAA in AD and DS cases, as well as in the 5XFAD and APP/PS1KI transgenic mouse lines of AD. This evidence concerns the gene APP and Alzheimer disease.